-
A Breakthrough in Diabetes Care: Afrezza Approved for Children and Adolescents
A New Chapter for Pediatric Diabetes Management For many families managing diabetes, the daily routine of injections can be a significant source of stress and discomfort. MannKind Corporation has recently reached a major milestone in diabetes treatment: the FDA has officially approved Afrezza (insulin human) inhalation powder for use in children and adolescents with diabetes.…
-
BIO-TECH STOCK CATALYST REPORT FOR WEEK OF 01-18-2026 TO 01-24-2026
We’re excited to announce the release of our latest bio tech stock catalyst report for the upcoming week. This new stock report highlights bio tech companies that have an upcoming important event to help traders and investors make informed decisions in today’s dynamic environment. Each stock symbol is a link to a stock quote page…
$ABBV, $AZN, $ELDN, $GMAB, $GNLX, $LLY, $LTRN, $MNKD, $NOV, $NVO, $NVS, $PFE, $SNY, biopharmaceutical, clinical-research, fda, new drug application, pr-newswire, press-releases